ClinicalTrials.gg
RecruitingNCT06960421XFITUpdated Oct 16, 2026

Exercise-based Frailty Intervention in Lung Transplantation (XFIT)

An interventional study of XFIT in Frailty and Lung Tranplant Candidate, sponsored by University of California, San Francisco. Recruiting at 4 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Other

How we know

Updated Oct 16, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Frailty with a site in United States — 48 open to participants now, 61 under way, 1 of them phase 3. Frailty · United States.

Planned enrollment
50th of 142
70 · median 42
Started
2026
with 7 others
No phase
93 of 185
27 open now
Primary completion
2029-07
later than 51 of 59 live
Registered
171st of 185
by date
Lead sponsor
5 of 185
University of California, San Francisco

Among the 185 studies in Frailty with a site in United States, this one is the 50th largest by planned enrollment of the 142 interventional ones that give a count, is one of 8 that started in 2026, is one of 93 with no phase, reaches primary completion later than 51 of the 59 other live ones, and was the 171st registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

48 of the 185 studies in Frailty with a site in United States are open now. Recruiting first, the newest first:

42 more — sign in →

All 48 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Frailty with a site in United States, or all of them as a file.
02

Study summary

The goal of XFIT study is to measure the safety of an 8-week telehealth-delivered exercise and behavioral training program to treat frailty in lung transplant candidates in their own home. The main questions XFIT aims to answer are:

  • Is XFIT safe?
  • Is XFIT feasible and acceptable by participants?
  • Is XFIT effective in improving frailty and physical function as reflected in patient-reported outcomes.

Participants will:

- Participate in the 8-week XFIT program or enhanced standard of care

Read the detailed description

We will randomize 70 patients who reflect the diversity and spectrum of illness seen in the general lung transplant candidate population to either XFIT or enhanced standard of care. An interventionalist with expertise in exercise physiology and remote interventions will deliver 8 weekly sessions using video-conference software in participants' homes. These sessions feature one-on-one exercise training and targeting of behavioral barriers to optimizing physical activity using motivational interviewing principles. Establishing safety is our primary outcome. We will secondarily establish feasibility and acceptability, and explore responsiveness six-minute walk distance, frailty, Patient Reported Outcomes . We anticipate that this first-of-its kind study in solid organ transplantation will establish fundamental safety, feasibility, and accessibility data needed inform larger scale interventions.

03

Conditions studied

  • Frailty
  • Lung Tranplant Candidate

Browse trials for

Keywords

  • frailty
  • lung transplant
  • prehabilitation
  • remote intervention
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Group 1

Inclusion Criteria:

  • Age 18 - 65 years
  • Lung Transplant Candidates
  • Speaks English or Spanish
  • ≤ 8LPM O2 on 6MWT
  • SPPB score ≤ 10

Exclusion Criteria:

  • Lives Alone
  • \< 18.0 kg/m2
  • Engaged in clinical pulmonary rehabilitation program
  • Severe pHTN (RHC mPAP ≥ 30 mmHg or TTE PASP ≥ 60mmHg or moderately/severely reduced RV systolic function on TTE
  • Deemed unsafe by site PI

Group 2

Inclusion Criteria:

  • Age 18 - 75 years
  • Speaks English or Spanish
  • ≤ 15LPM O2 on 6MWT
  • SPPB score ≤ 10

Exclusion Criteria:

  • Lives Alone
  • BMI \< 18.0 kg/m2
  • Engaged in clinical pulmonary rehabilitation program
  • Severely reduced RV systolic function on TTE
  • Deemed unsafe by site PI
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Active comparator
    XFIT

    XFIT is an 8-week telehealth-delivered, home-based exercise/behavior modification intervention. It integrates theoretical frameworks of behavior change to engage frail lung transplant candidates in program of pre-habilitation.

    Behavioral: XFIT

  • No intervention
    Enhanced standard of care

    Participants in ESC will be provided with individualized recommendations to improve physical frailty tailored to their baseline assessments, as well as contemporary information on treatments for physical frailty published by the NIH's Science of Frailty group (https://frailtyscience.org/). ESC participants will not engage in weekly treatment sessions, wear activity trackers throughout the intervention period, or receive the personalized psychological treatment provided to those in XFIT.

Interventions

  • BehavioralXFIT

    XFIT is an 8-week telehealth-delivered, home-based exercise/behavior modification intervention. It integrates theoretical frameworks of behavior change to engage frail lung transplant candidates in program of pre-habilitation.

06

What researchers measure

Primary outcomes

  1. Death

    Time frame: 8 weeks

  2. Major cardiovascular event

    Time frame: 8 weeks

  3. > 2 unplanned hospitalizations

    Time frame: 8 weeks

Secondary outcomes

  1. Desaturation

    Time frame: 8 weeks

  2. Coughing

    Time frame: 8 weeks

  3. Presyncope

    Time frame: 8 weeks

07

Study locations

1 of 4 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — An anonymized dataset with key study-related data will be made available to investigators upon request one-year after the publication of the primary study findings. Investigators will be able to make requests through Drs. Singer and Smith, who can facilitate such data management tasks. In addition, we will plan to provide a complete, anonymized dataset for deposition into online data repositories within three years of publication of our primary findings, for use in subsequent follow-up analyses or meta-analytic studies. We will also make annotated statistical analytical code available for public usage, in order to increase reproducibility of findings for future studies. We will also make available our final protocol. These data will be available in an online data repository for as long as the repository is able to host them. They will also be available for request from Drs. Singer and Smith.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: As detailed above. The trial is expected to run from July 2026 to June 2029.

Access criteria: As above.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jul 2029, 32 months later.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 32 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

Start moved once since we started tracking on Sep 25, 2026: Jul 2026 → Oct 2026, on Oct 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2025
First posted
May 7, 2025
StartEst.
Oct 22, 2026was Jul 2026
Primary completionEst.
Jul 1, 2029
CompletionEst.
Jul 1, 2029
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 16, 2026
Sites
4 sites changed recruiting status (3 now not yet recruiting, 1 now recruiting)
Show 4 sites
  • University of California,San Francisco · San Francisco, United Statesno status→Recruiting
  • Columbia University · New York, United Statesno status→Not yet recruiting
  • University of North Carolina · Chapel Hill, United Statesno status→Not yet recruiting
  • University of Pennsylvania · Philadelphia, United Statesno status→Not yet recruiting
Oct 16, 2026
Start date
Jul 15, 2026→Oct 22, 2026
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Not yet recruiting→Recruiting
    4 sites changed recruiting status (3 now not yet recruiting, 1 now recruiting)
    Show 4 sites
    • University of California,San Francisco · San Francisco, United Statesno status→Recruiting
    • Columbia University · New York, United Statesno status→Not yet recruiting
    • University of North Carolina · Chapel Hill, United Statesno status→Not yet recruiting
    • University of Pennsylvania · Philadelphia, United Statesno status→Not yet recruiting
    Start date Jul 15, 2026→Oct 22, 2026
    + 3 other changes: index terms, verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06960421
Responsible party
Sponsor
First posted
May 7, 2025
Start date
Oct 22, 2026 (estimated)
Primary completion
Jul 1, 2029 (estimated)
Completion
Jul 1, 2029 (estimated)
Last update
Oct 16, 2026

Study contacts

Legna Betancourt
Contact
legna.betancourt@ucsf.edu
415-476-8073
Jonathan Singer, MD, MS
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion